EKF Diagnostics Holdings plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that pr… Read more
EKF Diagnostics Holdings plc (EKDHF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.068x
Based on the latest financial reports, EKF Diagnostics Holdings plc (EKDHF) has a cash flow conversion efficiency ratio of 0.068x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.92 Million) by net assets ($72.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EKF Diagnostics Holdings plc - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how EKF Diagnostics Holdings plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
EKF Diagnostics Holdings plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EKF Diagnostics Holdings plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Theratechnologies Inc.
NASDAQ:THTX
|
-0.444x |
|
Hangzhou Gisway Information Technology Co. Ltd. A
SHE:301390
|
N/A |
|
AKATSUKI INC.
F:7QT
|
N/A |
|
Jeju Air Co Ltd
KO:089590
|
0.211x |
|
Hansa Biopharma AB
ST:HNSA
|
0.253x |
|
Wuxi Xinan Technology Co. Ltd. A
SHE:301170
|
N/A |
|
Zentalis Pharmaceuticals Llc
NASDAQ:ZNTL
|
-0.107x |
|
CVC Brasil Operadora e Agencia
SA:CVCB3
|
0.347x |
Annual Cash Flow Conversion Efficiency for EKF Diagnostics Holdings plc (2001–2024)
The table below shows the annual cash flow conversion efficiency of EKF Diagnostics Holdings plc from 2001 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $73.21 Million | $13.66 Million | 0.187x | +101.62% |
| 2023-12-31 | $68.22 Million | $6.31 Million | 0.093x | -28.84% |
| 2022-12-31 | $74.52 Million | $9.69 Million | 0.130x | +20.30% |
| 2021-12-31 | $94.74 Million | $10.24 Million | 0.108x | -38.80% |
| 2020-12-31 | $78.20 Million | $13.81 Million | 0.177x | +146.43% |
| 2019-12-31 | $71.17 Million | $5.10 Million | 0.072x | -44.98% |
| 2018-12-31 | $63.90 Million | $8.32 Million | 0.130x | -12.96% |
| 2017-12-31 | $60.50 Million | $9.05 Million | 0.150x | +2.02% |
| 2016-12-31 | $60.97 Million | $8.94 Million | 0.147x | +260.04% |
| 2015-12-31 | $46.75 Million | $-4.29 Million | -0.092x | -68.80% |
| 2014-12-31 | $87.38 Million | $-4.74 Million | -0.054x | -210.70% |
| 2013-12-31 | $40.92 Million | $2.01 Million | 0.049x | +20.93% |
| 2012-12-31 | $39.43 Million | $1.60 Million | 0.041x | +288.32% |
| 2011-12-31 | $37.43 Million | $-806.00K | -0.022x | +64.04% |
| 2010-12-31 | $23.53 Million | $-1.41 Million | -0.060x | +50.22% |
| 2009-12-31 | $5.62 Million | $-676.00K | -0.120x | +5.74% |
| 2008-12-31 | $5.07 Million | $-647.00K | -0.128x | -210.05% |
| 2007-12-31 | $4.98 Million | $577.00K | 0.116x | +160.35% |
| 2006-12-31 | $4.30 Million | $-826.00K | -0.192x | -3668.00% |
| 2005-12-31 | $3.71 Million | $20.00K | 0.005x | +101.97% |
| 2004-12-31 | $3.12 Million | $-852.00K | -0.274x | -2390.00% |
| 2003-12-31 | $2.46 Million | $-27.00K | -0.011x | -498.46% |
| 2002-12-31 | $2.90 Million | $8.00K | 0.003x | -99.58% |
| 2001-12-31 | $214.00K | $142.00K | 0.664x | -- |